CLONID-XR

Welcome to the Brand page for “CLONID-XR”, which is offered here for Extended release capsules and suspension for oral administration of the drug clonidine, intended for the treatment of hypertension and tourette's syndrome;.

Its status is currently believed to be active. Its class is unavailable. “CLONID-XR” is believed to be currently owned by “NextWave Pharmaceuticals Incorporated”.


Owner:
NEXTWAVE PHARMACEUTICALS INCORPORATED
Owner Details
Description:
Extended release capsules and suspension for oral administration of the drug clonidine, intended for the treatment of hypertension and Tourette's syndrome;
Categories: EXTENDED RELEASE CAPSULES SUSPENSION